KSS (KSS)

$1.4B
Market Cap
5.3
P/E Ratio
1.43
Beta
4.01%
Dividend Yield
Piotroski 6/9Altman Z 1.6 DistressBeneish M -3.11 CleanROIC−WACC -4.2%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 1.6.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency of KSS reveals a significant structural challenge, with an ROIC of 4.5% falling substantially below the estimated WACC of 8.7%, resulting in a negative spread of -4.2%. This indicates that current operations are eroding shareholder value rather than generating returns above the cost of capital. Despite this capital inefficiency, profitability metrics present a mixed picture: while net margins have contracted to just 1.8% and revenue growth has turned negative at -4.3%, gross margins remain robust at 40.6%. This divergence suggests that operating leverage or rising costs are compressing bottom-line earnings despite strong pricing power or product mix in the top line. Financial health indicators offer a nuanced view of stability; the Piotroski F-Score of 6/9 signals moderate financial strength, yet an Altman Z-Score of 1.6 places the company in the "gray zone" for potential distress, contrasting sharply with a Beneish M-Score of -3.11 that strongly suggests low earnings manipulation risk and high fundamental quality relative to peers.

Valuation metrics currently reflect extreme pessimism regarding future performance. The stock trades at a P/E ratio of 5.3x, which represents a severe discount compared to historical averages and sector norms, implying the market has priced in a prolonged period of value destruction or permanent capital impairment. This low multiple stands in stark contrast to the DCF-derived fair value of $343, suggesting that current pricing may be disconnected from intrinsic value assumptions if growth constraints are temporary rather than structural. The disconnect between the depressed trading price and the model-implied valuation highlights a critical divergence: while fundamentals show signs of operational stress through negative revenue trends and capital inefficiency, the market appears to have already factored in these risks into an exceptionally low entry point that may not fully account for potential mean reversion or margin stabilization.

The risk-reward profile is defined by high volatility driven by deteriorating sales momentum and a precarious solvency position indicated by the Altman score, yet tempered by evidence of clean accounting practices. Investors must weigh the danger of continued value erosion against the possibility that the current valuation has over-penalized the stock for cyclical headwinds rather than fundamental decay. The combination of negative revenue growth and capital destruction creates a compelling case for caution regarding near-term trajectory, while the low multiple offers a potential asymmetric opportunity only if management can successfully reverse the ROIC-WACC spread or stabilize top-line momentum in subsequent quarters.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6.7%8.7%10.7%
2%$438$298$222
3%$544$343$246
4%$729$407$277

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.7%, terminal growth 3%. Fair value $343 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
1.6
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-3.11
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

40.6%
Gross Margin
1.8%
Net Margin
4.5%
ROIC
8.7%
WACC
ROIC − WACC Spread: -4.2%— Negative spread.
-4.3%
Revenue Growth (YoY)
+149.5%
Earnings Growth (YoY)
1.0B
Free Cash Flow
6%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

2.30x
Debt / Equity
1.46x
Current Ratio
2.2x
Interest Coverage
0.6x
Net Debt / EBITDA
46.49%
FCF Yield
1.3B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $-0.22
Act: $-0.13
+41.8%
Q3
✓ Beat
Est: $0.30
Act: $0.56
+85.5%
Q2
✓ Beat
Est: $-0.16
Act: $0.10
+160.8%
Q1
✓ Beat
Est: $0.84
Act: $1.07
+26.7%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

8.6
Forward P/E
PEG Ratio
0.35
Price/Book
4M
Avg Volume
$25.22
52W High
$6.04
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$27M
Tracked Passive Exposure
6
ETFs Holding KSS
0.07%
Avg Weight in ETFs
$37B
Total ETF AUM

When investors buy or sell ETFs like XRT or SLYV, the fund manager is mechanically forced to buy or sell KSS shares regardless of KSS's individual fundamentals. We estimate $27M of passive capital is structurally linked to KSS through 6 tracked ETFs. Passive flows have a limited but growing influence on KSS's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in KSS to visualize passive redemption contagion across ETFs and collateral stocks.

KSS Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
KSSEpicenterSPSMETFSPTMETFVCRETFAMZNLow RiskTSLALow RiskHDLow RiskMCDLow RiskTJXLow Risk
KSS Price Drop (%)0

If KSS (KSS) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Amazon.com Inc. (AMZN) as the most exposed collateral stock, sharing 1 ETFs with KSS. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

KSS Ownership Dynamics

Ticker
KSS

Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

KSS Capital Efficiency

How efficiently does KSS convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$1.0B
EBITDA
$1.3B
FCF Conversion
76%
Reinvestment Rate
24%
76% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
4.5%
ROIC − WACC Spread
-4.2%

KSS converts 76% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-4.2%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1413$12.08$157.04
2026-05-07645$14.41$9,294.45
2026-05-0676$14.25$1,083
2026-05-0592$14.19$1,305.48
2026-05-0497$14.66$1,422.02
2026-05-0138,868$14.17$550,759.56
2026-04-2714,807$14.69$217,514.83
2026-04-221,491$15.87$23,662.17
2026-04-21673$14.61$9,832.53
2026-04-201,000$14.52$14,520
2026-04-07121$13.33$1,612.93
2026-04-0230,241$12.88$389,504.08
2026-04-0155$12.90$709.5
2026-03-2539,902$12.35$492,789.7
2026-03-242,420$13.15$31,823
2026-03-2360$12.43$745.8
2026-03-19614,192$12.03$7.4M
2026-03-18673,138$12.69$8.5M
2026-03-1743,045$13.04$561,306.8
2026-03-132,822$13.27$37,447.94
2026-03-09112,208$15.12$1.7M
2026-02-2583$17.71$1,469.93
2026-02-24899$18.14$16,307.86
2026-02-23581$18.78$10,911.18
2026-02-1964$19.32$1,236.48
2026-02-10750$17.55$13,162.5
2026-02-051$18.16$18.16
2026-02-03513$17.97$9,218.61
2026-01-302,311$16.90$39,055.9
2026-01-298,755$17.22$150,761.1

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare KSS to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.